Abstract:Pathogenic bacteria demonstrate incredible abilities to evade conventional antibiotics through the development of resistance and formation of dormant, surface-attached biofilms. Therefore, agents that target and eradicate planktonic and biofilm bacteria are of significant interest. We explored a new series of halogenated phenazines (HP) through the use of N-aryl-2-nitrosoaniline synthetic intermediates that enabled functionalization of the 3-position of this scaffold. Several HPs demonstrated potent antibacterial and biofilm-killing activities (e.g., HP 29, against methicillin-resistant Staphylococcus aureus: MIC = 0.075 μM; MBEC = 2.35 μM), and transcriptional analysis revealed that HPs 3, 28, and 29 induce rapid iron starvation in MRSA biofilms. Several HPs demonstrated excellent activities against Mycobacterium tuberculosis (HP 34, MIC = 0.80 μM against CDC1551). This work established new SAR insights, and HP 29 demonstrated efficacy in dorsal wound infection models in mice. Encouraged by these findings, we believe that HPs could lead to significant advances in the treatment of challenging infections.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop new antibacterial agents to address the antibiotic resistance of pathogenic bacteria and the problem of biofilm formation. Specifically, the article explored a new series of halogenated phenazine (HP) compounds and achieved functional modification at the 3 - site of this compound through a modular synthesis route of N - aryl - 2 - nitrosoaniline intermediates. These new compounds showed significant antibacterial activity against drug - resistant bacteria in both the planktonic state and in biofilms. ### Detailed analysis: 1. **Background and problem description**: - Pathogenic bacteria can evade the action of traditional antibiotics through multiple mechanisms, such as target mutations, membrane chemical changes, and increased efflux pump activity. - The biofilms formed by bacteria are the main cause of chronic infections because the dormant cells within them have a natural tolerance to antibiotics. - Therefore, it is crucial to develop new antibacterial agents that can effectively eliminate planktonic bacteria and biofilms. 2. **Research objectives**: - Explore a new series of halogenated phenazine (HP) compounds and, by functionalizing and modifying their 3 - sites, hope to discover more effective antibacterial agents. - Verify the antibacterial effects of these compounds on multiple drug - resistant strains (such as MRSA, VRE, etc.) and their biofilms. 3. **Methods and techniques**: - A series of new halogenated phenazine compounds were prepared using N - aryl - 2 - nitrosoaniline as a synthetic intermediate through a modular synthesis route. - A detailed structure - activity relationship (SAR) study was carried out on these compounds. - Their antibacterial activities were evaluated through MIC (minimum inhibitory concentration) and MBEC (minimum biofilm eradication concentration) experiments. 4. **Main findings**: - Several HP compounds (such as HP 29) showed extremely strong antibacterial activity against drug - resistant strains such as MRSA (MIC = 0.075 μM) and were able to effectively eliminate biofilms (MBEC = 2.35 μM). - Transcriptome analysis showed that some HP compounds (such as HP 29) could rapidly induce an iron - starvation response in MRSA biofilms, thereby affecting the viability of bacteria. - In a mouse dorsal wound - infection model, HP 29 also showed good efficacy. In conclusion, this study aims to provide new treatment strategies for solving drug - resistant bacteria infections by developing new halogenated phenazine compounds.

A Modular Synthetic Route Involving N -Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents

A Highly Potent Class of Halogenated Phenazine Antibacterial and Biofilm-Eradicating Agents Accessed Through a Modular Wohl-Aue Synthesis

Structure-Activity Relationships of A Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium Tuberculosis

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, Synthesis, and Evaluation of Carbonate-Linked Halogenated Phenazine-Quinone Prodrugs with Improved Water-Solubility and Potent Antibacterial Profiles

An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication and Prodrug Exploration.

An Ether-Linked Halogenated Phenazine-Quinone Prodrug Model for Antibacterial Applications.

Modular Synthetic Routes to Fluorine-Containing Halogenated Phenazine and Acridine Agents That Induce Rapid Iron Starvation in Methicillin-Resistant Staphylococcus aureus Biofilms

Halogenated Phenazines That Potently Eradicate Biofilms, MRSA Persister Cells in Non‐Biofilm Cultures, and Mycobacterium Tuberculosis

Design, synthesis and biological evaluation of a halogenated phenazine-erythromycin conjugate prodrug for antibacterial applications

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives

Design, Synthesis, and Antimicrobial Evaluation of New Thiopyrimidine–Benzenesulfonamide Compounds

Design, Synthesis and Biological Evaluation of 3-(4-halophenyl)-3-oxopropanal and Their Derivatives As Novel Antibacterial Agents

Halogenated Quinolines Bearing Polar Functionality at the 2-Position: Identification of New Antibacterial Agents with Enhanced Activity Against Staphylococcus Epidermidis.

<i>N</i>-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification

Synthesis, Antimicrobial Evaluation and Docking Study of Novel 3,5-Disubstituted-2-Isoxazoline and 1,3,5-Trisubstituted-2-Pyrazoline Derivatives

Synthesis and in Vitro Antibacterial Activity of Novel Naphthyridinone Derivatives

Novel nitro-heteroaromatic antimicrobial agents for the control and eradication of biofilm-forming bacteria

Novel quinoline/thiazinan-4-one hybrids; design, synthesis, and molecular docking studies as potential anti-bacterial candidates against MRSA

Design, synthesis and biological evaluations of quaternization harman analogues as potential antibacterial agents

In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy